Engineering T Cell Receptors for Optimal Targeting of Established Tumors

$296,876P01FY2008CANIH

University Of Chicago, Chicago IL

Investigators

David M Kranzcontact

Linked publications & trials

Paper 28445461 Paper 28413217 Paper 28077434 Paper 27317748 Paper 26060072 Paper 25959818 Paper 25728991 Paper 25630967 Paper 25517615 Paper 25217157 Paper 24482750 Paper 24455752 Paper 24434209 Paper 24408925 Paper 24382348 Paper 24133971 Paper 23954306 Paper 23673862 Paper 23637340 Paper 23630355 Paper 23597565 Paper 23579075 Paper 23420038 Paper 23363817 Paper 23122052 Paper 23052828 Paper 22990672 Paper 22982754 Paper 22961781 Paper 22949678 Paper 22926060 Paper 22722449 Paper 22717982 Paper 22511579 Paper 22374983 Paper 22312128 Paper 22233579 Paper 22230570 Paper 22212863 Paper 22102724 Paper 21949793 Paper 21930765 Paper 21753797 Paper 21451107 Paper 21300764 Paper 21159619 Paper 21074066 Paper 20921286 Paper 20708157 Paper 20479270 Paper 20460520 Paper 20331471 Paper 20226692 Paper 20200275 Paper 19923452 Paper 19553539 Paper 19426219 Paper 19349616 Paper 19293190 Paper 19159293 Paper 18977672 Paper 18836717 Paper 18684640 Paper 18483384 Paper 18317595 Paper 18316622 Paper 18174897 Paper 18004565 Paper 17973257 Paper 17875753 Paper 17627067 Paper 17548594 Paper 17431181 Paper 17305480 Paper 17210731 Paper 17038624 Paper 17028589 Paper 16982889 Paper 16762725 Paper 16674971 Paper 16459066 Paper 16374636 Paper 15934727 Paper 15905561 Paper 15778509 Paper 15749875 Paper 15735047 Paper 15705478 Paper 15493363 Paper 15489136 Paper 15077191 Paper 14998777 Paper 14981514 Paper 14978132 Paper 14871849 Paper 14670335 Paper 14568931 Paper 12962272 Paper 12828864 Paper 12804851

View original record on NIH RePORTER →